Fig. 2From: Role of PET/CT in post-therapeutic assessment of bronchogenic carcinomaa–d Axial CT and fused PET/CT images before and after therapy. A 59-year-old male patient, with history of left-sided bronchogenic cancer (adenocarcinoma), received chemotherapy and referred for follow-up after 3 months, showing interval progression in the size and metabolic activity of the previously reported hypermetabolic left lung lower lobar soft tissue mass lesion (arrow) measuring about 4.5 × 5.5 cm and achieving 13.6 SUVmax on current examination (compared to 3.1 × 3.4 cm and achieving 8.4 SUVmax on previous study). SUV average of the liver background measuring 1.5. e, f Whole body MIP images before and after therapy showing progression of the primary left lung neoplasiaBack to article page